We have extensive experience of finding hits using target appropriate methodologies. From biochemical assays, DEL, ASMS, in silico screening, and fragment-based drug discovery (FBDD) – an area in which we are recognised world-leaders. Starting with these techniques, singly or in combination, we have identified hits that have been developed into leads and clinical candidates with our collaborators against a wide range of challenging drug targets.
Biochemical Assays
Biochemical assay development
New technology development
